Cargando…
Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
Antiretroviral therapy containing an integrase strand transfer inhibitor (INSTI) plus two NRTIs has become the recommended treatment for antiretroviral-naive HIV-1-infected patients in the updated guidelines. We aimed to determine the prevalence of INSTI-related mutations in Taiwan. Genotypic resist...
Autores principales: | Chang, Sui-Yuan, Lin, Pi-Han, Cheng, Chien-Lin, Chen, Mao-Yuan, Sun, Hsin-Yun, Hsieh, Szu-Min, Sheng, Wang-Huei, Su, Yi-Ching, Su, Li-Hsin, Chang, Shu-Fang, Liu, Wen-Chun, Hung, Chien-Ching, Chang, Shan-Chwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078839/ https://www.ncbi.nlm.nih.gov/pubmed/27779200 http://dx.doi.org/10.1038/srep35779 |
Ejemplares similares
-
Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
por: Dow, Dorothy E., et al.
Publicado: (2014) -
A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants
por: Sayyed, Sharif Karim, et al.
Publicado: (2023) -
Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test
por: Sun, Hsin-Yun, et al.
Publicado: (2015) -
Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco
por: Alaoui, Najwa, et al.
Publicado: (2018) -
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
por: Zhao, Alexa Vyain, et al.
Publicado: (2022)